All In MedTech

FDA Clearance Tracker · P950037

DROMOS DR/DR-A AND DROMOS SR/SR-B CARDIAC PACING SYSTEMS

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Oct 11, 1996 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Oct 11, 1996

Approved

Time to decision

330 days

Received Nov 16, 1995. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P950037
Device name
DROMOS DR/DR-A AND DROMOS SR/SR-B CARDIAC PACING SYSTEMS
Applicant location
Lake Oswego, OR
Received
Nov 16, 1995
Decided
Oct 11, 1996
Decision
Approved
Supplements
283 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III
Regulation
21 CFR 870.3610

Every decision under product code DXY

FDA's approval statement

As written in FDA's record.

RATE ADAPTIVE PACING WITH THE DROMOS DR AND DROMOS SR PULSE GENERATORS IS INDICATED FOR PATIENTS EXHIBITING CHRONOTROPIC INCOMPETENCE AND WHO WOULD BENEFIT FROM INCREASED PACING RATES CONCURRENT WITH PHYSICAL ACTIVITY

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code DXY. The earliest in FDA's data is K760757, decided Nov 11, 1976.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Biotronik, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.